Signos

Signos

Private
Burlingame, CaliforniaHealthcare & Life Scienceshttps://www.signos.com

Last Round

Early Funding

May 27, 2026

Total Funding Raised

$57M

Company Overview

Signos is a health and wellness company that offers a weight loss application that recommends meals and exercises while providing real-time glucose monitoring and metabolism visualization through its software and wearable device.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Health IoT, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Hardware + Subscription

AI Layer

Application

Keywords

continuous glucose monitoringCGMweight managementmetabolic healthCGM for weight lossFDA-cleared appmetabolic trackingover-the-counter systemOTCAI health coachpersonalized recommendationsdirect-to-consumerwearable biosensorsubscription modelDexcom Steloemployer health program

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Signos Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Signos Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 27, 2026
Series BOct 24, 2023
Series ANov 10, 2021
SeedJan 1, 2021

Key People

Founding team and executive leadership

Sharam Fouladgar-Mercer

Co-Founder And CEO

Founding Team

Roger Neel

Chief Technology Officer

Executive Team

Signos Investors

Notable investors and investment history

InvestorRounds
GVEarly Funding, Series B, Series A
Dexcom VenturesSeries B
Courtside VenturesSeries A, Seed
Samsung NEXT VenturesSeries B
Tau VenturesSeed, Series A
Cheyenne VenturesSeries B
Samsung NextSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 27, 2026

    $20M raised with participation from GV and DexCom.

  • Aug 20, 2025

    Launched FDA-cleared Glucose Monitoring solution for metabolic health.

Signos Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Signos Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Signos's valuation, stock price, and market status.

Firmographic Details

HeadquartersBurlingame, California
Employee Range118
Year Founded2020
Last FundingMay 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.